| 000 | 01935nam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 091015s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2009.No.C | ||
| 100 | 0 | _aNoura Mahmoud Ali Selim | |
| 245 | 1 | 0 |
_aChemokine receptor 5 (CCR5) gene polymorphism in patients with diabetic nephropathy in type II diabetes / _cNoura Mahmoud Ali Selim ; Supervised Badawy Mohamed Elkholy , Manal Mohamed Kamal , Mohamed Mahmoud Nasrallah |
| 246 | 1 | 5 | _aدراسة الطفرة الجينية لمستقبلات المحفزات الكيميائية سى سى ار 5 فى مرضى القصور الكلوى السكرى فى النوع الثانى من مرض السكر |
| 260 |
_aCairo : _bNoura Mahmoud Ali Selim , _c2009 |
||
| 300 |
_a138P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aDiabetic nephropathy is a serious complication in individuals with type II diabetes . Chemokines and their receptors have been implicated in the development of diabetic nephropathy . The aim of this work is to investigate the possible association of chemokine receptor CCR G59029 agene polymoephism with diabetic nephropathy in patients with type !! diabetes in order to find out the pathogenesis risk of development and progression of nephropathy in type II diabetic patients | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChemokine receptor 5 (CCR5) | |
| 653 | 4 | _aDiabetic nephropathy | |
| 653 | 4 | _aGene polymorphism | |
| 700 | 0 |
_aBadawy Mohamed Elkholy , _eSupervisor |
|
| 700 | 0 |
_aManal Mohamed Kamal , _eSupervisor |
|
| 700 | 0 |
_aMohamed Mahmoud Nasrallah , _eSupervisor |
|
| 902 | _a1 | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c24097 _d24097 |
||